Objective: Exogenous application of 20-hydroxyeicosatetraenoic acid (20-HETE) to small (300-500 Mm) porcine coronary arteries elicits contraction by activating the Rho kinase and increasing the sensitivity of contractile proteins to Ca 2+ . Here, we determined whether 20-HETE is involved in the regulation of coronary artery tone as well as its role in the modulation of endothelium-derived hyperpolarizing factor (EDHF)-mediated responses. Methods and results: Small porcine coronary arteries expressed cytochrome P450 (CYP) 4A, as demonstrated by Western blot analysis, and generated 20-HETE. Moreover, 20-HETE production was increased two-and threefold over basal levels in response to isometric stretch or the thromboxane analogue U46619, respectively, and was inhibited by the CYP 4A inhibitor N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS). In vascular reactivity studies, DDMS attenuated U46619-induced contractions and induced a concentration-dependent but endothelium-independent relaxation of precontracted arterial rings. Endogenously generated 20-HETE significantly inhibited the EDHFmediated relaxation of coronary arteries, which was potentiated by the phospholipase A 2 inhibitors AACOCF 3 and ONO-RS-082, as well as by the N-hydroxylase inhibitors 17-octadecynoic acid and DDMS. EDHF-mediated relaxation was not affected by either the nonselective epoxygenase inhibitors miconazole and clotrimazole or the CYP 2C inhibitor sulfaphenazole but was abolished by the Na-K-ATPase inhibitor, ouabain. Exogenous application of 20-HETE inhibited EDHF-mediated relaxations and caused a concomitant increase in the phosphorylation of protein kinase Ca (PKCa). This effect was reversed by the PKC inhibitor Ro-318220 and mimicked by the PKC activator phorbol-12 myristate 13-acetate. Conclusions: These results indicate that vascular tone in small porcine coronary arteries is partly determined by the endogenous production of 20-HETE. In addition, 20-HETE functionally antagonizes EDHF-mediated relaxation via a PKCA-dependent mechanism, probably involving the inhibition of the Na-K-ATPase.
Introduction
The regulation of vascular tone involves a complex interplay between vasoconstrictor and vasodilator stimuli. The myogenic response is a main determinant of vascular tone in situ and data gathered over the last 15 convincingly shown a link between vascular 20-hydroxyeicosatetraenoic acid (20-HETE) generation and myogenic responses in renal, cerebral, and mesenteric arteries [1] [2] [3] [4] . In smooth muscle cells, 20-HETE is endogenously produced by W-hydroxylases of the cytochrome P450 (CYP) 4A family following an increase in [Ca 2+ ] i [5, 6] . Once formed, 20-HETE increases smooth muscle tone (and enhances sensitivity to vasoconstrictor agents) by inhibiting large conductance Ca 2+ -dependent K + channels (K Ca + ) [7] , thus inducing depolarization and contraction (for review, see Ref. [8] ). 20-HETE has also been linked with the activation of protein kinase C (PKC) [9] , the inhibition of the Na-K-ATPase [10, 11] as well as to the activation of the Rho kinase and the sensitization of the contractile apparatus to Ca 2+ [12] . Endothelium-derived vasodilator autacoids such as nitric oxide (NO), prostacyclin and the endothelium-derived hyperpolarizing factor (EDHF) are able to modulate the myogenic response. To date, only NO has been reported to interfere with the formation and actions of 20-HETE. Indeed, the NO-mediated inhibition of 20-HETE formation has been proposed to account for the natriuretic and diuretic actions of NO [13] , as well as the cyclic GMP-independent relaxant effects of NO in renal and cerebral arteries [14] [15] [16] .
Since 20-HETE and EDHF appear to share common targets; that is, both may regulate vascular tone by influencing K Ca + channels as well as the Na-K-ATPase, the aim of the present investigation was to determine whether the tone of small porcine coronary arteries reflects a balance between the activity of the vasodilator EDHF and the endogenous generation of the constrictor 20-HETE.
Materials and methods

Materials
AACOCF 3 was purchased from Calbiochem, bradykinin and charybdotoxin were from Bachem Biochemica (Heidelberg, Germany), 2-( p-Amylcinnamoyl)amino-4-chlorobenzoic acid (ONO-RS-082) was from Biomol (Hamburg, Germany), U46619 (9,11-dideoxy-epoxymethano-prostaglandin F 2 ) was from Alexis Biochemicals (Grqnberg, Germany), and 20-HETE was from Cayman Chemical (Massy, France). N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) was synthesized in the laboratory of Dr J.R. Falck as previously described [17] . Phorbol-12-myristate-13-acetate (PMA) and all other drugs were purchased from Sigma (Deisenhofen, Germany).
Vascular reactivity studies
Porcine hearts were obtained from a local slaughterhouse, placed immediately into ice-cold HEPES-Tyrode solution (composition in mmol/L: NaCl 137, KCL 2.7, CaCl 2 1.8, MgCl 2 0.5, NaH 2 PO 4 0.36, glucose 5, HEPES 10), and transported to the laboratory. Second branches of coronary arteries (internal diameter 300-500 Am) were dissected, cleaned of adventitial adipose and connective tissue, and cut into 4-mm-long rings. These rings were mounted on stainless steel triangles connected to a force transducer (Hugo Sachs Elektronik-Harvard Apparatus, Germany) and a rigid support for measurement of isometric force in organ baths containing Tyrode's solution of the following composition (mmol/L): NaCl 132, KCl 4, CaCl 2 1.6, MgCl 2 0.98, NaHCO 3 23.8, NaH 2 PO 4 0.36, glucose 10, Ca-Titriplex 0.05, diclofenac 0.01, and gassed with 20% O 2 , 5% CO 2 , and 75% N 2 to give a pO 2 of approximately 140 mmHg and pH 7.4 at 37 8C, as described [12] . Passive tension was gradually adjusted over a 60-min period to 1 g, thereafter arterial rings were repeatedly exposed to a modified Tyrode's solution rich in KCl (80 mmol/L) until stable contractions were obtained. The presence of functional endothelium was assessed in all preparations by the ability of bradykinin (1 Amol/L) to induce relaxation of vessels precontracted with U46619 (0.1 Amol/ L) and vessels exhibiting less than 80% relaxation were discarded.
Immunoblotting
Endothelium-intact rings of porcine coronary artery were incubated for 30 min at 37 8C in modified Tyrode's solution and stimulated as described in Results. Vessels were then frozen in liquid N 2 , ground to a powder and suspended in Triton X-100 lysis buffer. Following centrifugation (14,000Âg, 15 min at 4 8C) Triton-soluble and -insoluble proteins were heated with SDS-PAGE sample buffer, separated by SDS-PAGE (8%), and transferred to a nitrocellulose membrane as previously described [18] . Proteins were detected using their respective antibodies, and visualized by enhanced chemiluminescence using a commercially available kit (Amersham, Germany).
The polyclonal CYP 4A antibody was kindly provided by Dr. David Harder (Milwaukee, WI) and the CYP 2C antibody was purified by Eurogentec (Seraing, Belgium) from the serum of rabbits immunized with a CYP 2C9 peptide (RRRKLPPGPTPLPIC). The phosphoprotein kinase C (PKC pan) and the phospho-PKCa antibodies were from Cell Signaling Technology (Frankfurt am Main, Germany), the PKCa antibody was from BD Biosciences Pharmingen (Heidelberg, Germany), and the h-actin antibody from Sigma (Deisenhofen, Germany).
Measurement of 20-HETE and EET levels in isolated arteries
Coronary artery rings were mounted in organ chambers as described above. Rings were either incubated without stretching or basal tension was adjusted to 1 g for 60 min. Thereafter, vessels were rapidly frozen in liquid nitrogen and ground to a powder. 20-HETE levels were assessed as described [19] with slight modifications. Briefly, following homogenization in 0.2 mol/L KCl containing 0.01% butylated hydroxytoluene (BHT) as an antioxidant and prostaglandin B1 (PGB1) as an internal standard, 20-HETE was extracted from the samples by addition of an equal volume of ethyl acetate containing 0.005% BHT and 0.1% formic acid. This was repeated twice and the combined organic phases were evaporated under a stream of nitrogen. Dried samples were dissolved in acetonitrile/methanol/water (40:10:50, v/v/v) and subjected to isocratic reversed-phase (RP) HPLC with online photodiode array detection (PDAD). RP-HPLC was carried out on octadecylsilyl columns with a mobile phase of acetonitrile/methanol/water/ formic acid (52:6:42:0.001). 20-HETE was detected at 204 nm, identified by spectra plot on the peak maximum and co-elution with the commercial 20-HETE standard, and assessed by internal standard method using PGB1. Analysis of full UV spectra (190-340 nm) provided by PDAD allowed accurate identification and quantification of 20-HETE by peak purity control and subtraction of possible coeluting material.
Statistical analysis
Relaxation is expressed as a percentage of the contraction obtained with U46619 and R max represents the maximal relaxation recorded in response to the cumulative addition of a given agonist. pD 2 (Àlog EC 50 ) values were calculated by using commercially available software (Prism 2.01, GraphPAD software, San Diego, CA). Data are expressed as meanFS.E.M. and statistical evaluation was performed using Students t test for unpaired data or one-way analysis of variance (ANOVA) followed by a Bonferroni's t test, where appropriate. Values of Pb0.05 were considered statistically significant.
Results
CYP 4A protein expression and 20-HETE production in small porcine coronary arteries
The expression of CYP 4A and CYP 2C protein was assessed in large and small porcine coronary arteries by Western blotting. The CYP 4A antibody used recognized a 52-kDa band in porcine kidney as well as in the small coronary arteries while only a weak signal was detected in the large porcine coronary artery (Fig. 1A) . The CYP 2C epoxygenase, on the other hand was clearly expressed in large porcine coronary arteries while only a weak signal could be detected in smaller arteries.
A basal production of 20-HETE was detected in small porcine coronary arteries maintained without stretch. DDMS (25 Amol/L) slightly, but nonsignificantly, reduced 20-HETE levels in these arteries (Fig. 1B) . Isometric stretch of the vessel (1 g, 60 min), however, led to a 1.6-fold increase in 20-HETE production while isometric stretch and U46619 increased 20-HETE production by 2.1-fold. Both responses were prevented by the CYP 4A inhibitor (Fig. 1B) .
Effect of CYP 4A inhibition on coronary artery tone
To determine whether 20-HETE was generated in small porcine coronary arteries and contributes to the agonistinduced development of vascular tone, we assessed the effects of DDMS using two different protocols.
Preincubation of small porcine coronary artery rings with DDMS (25 Amol/L) resulted in a pronounced rightward shift in the U46619-induced concentration-contraction curve ( Fig. 2A) and slightly reduced the maximal contraction obtained. The pD 2 values for U46619 was were 7.21F0.13 In small coronary artery rings precontracted with U46619 to 80% of the maximal KCl (80 mmol/L)-induced contraction, DDMS (5-25 Amol/L) elicited a concentration-dependent but endothelium-independent relaxation (Fig. 2B) . DDMS was however unable to induce relaxation in large porcine coronary arteries which express little or no CYP 4A (data not shown).
Pharmacological characterization of the endotheliumdependent relaxation of small porcine coronary arteries
In U46619-precontracted coronary artery rings, bradykinin elicited endothelium-and concentration-dependent relaxations. The concentration-relaxation curve to bradykinin was shifted to the right ( Pb0.05, n=7) and the maximal relaxation slightly but significantly ( Pb0.05, n=7) attenuated when experiments were performed in the presence of N x -nitro-l-arginine (l-NA, 300 Amol/L, Fig. 3A ). This NO-and prostacyclin-independent relaxation can be attributed to an EDHF since it was sensitive to depolarizing concentrations of KCl, as well as to the combination of the K Ca + channel inhibitors charybdotoxin and apamin (each 100 nmol/L). The EDHF-mediated relaxation of small porcine coronary arteries was also sensitive to the Na-K-ATPase inhibitor ouabain (500 nmol/L, Fig. 3A) .
Since the EDHF-mediated relaxation of larger porcine coronary arteries has been linked to the activation of phospholipase A 2 (PLA 2 ) and the generation of epoxyeicosatrienoic acids (EETs) by a CYP epoxygenase [20] , we determined the effects of interfering with these processes on the relaxation of small coronary arteries.
The PLA 2 inhibitors, AACOCF3 (10 Amol/L) and ONO-RS-082 (10 Amol/L) significantly enhanced the EDHFmediated relaxation to bradykinin (Fig. 3B) . pD 2 values were: 6.89F0.41 vs. 7.32F0.117 and 7.4F0.14 for control, AACOCF3, and ONO-RS-082, respectively (n=6, Pb0.05). Inhibition of CYP epoxygenases using miconazole (3 Amol/ L), clotrimazole (3 Amol/L), or sulfaphenazole (1 Amol/L) failed to influence the bradykinin-induced EDHF-mediated relaxation (Fig. 3C) . However, the N-hydroxylase inhibitors 17-octadecynoic acid (17-ODYA, 10 Amol/L) and DDMS (25 Amol/L) induced a significant leftward shift in the concentration-relaxation curve to bradykinin (Fig. 3D) . pD 2 values were 6.85F0.20 vs. 7.42F0.06 and 7.50F0.10 for control, DDMS, and 17-ODYA, respectively (n=6, Pb0.01).
Effect of 20-HETE on EDHF-mediated relaxation
Since the EDHF-mediated relaxation of small porcine coronary arteries was sensitive to ouabain and 20-HETE is reported to inhibit the activation of the Na-K-ATPase via a protein kinase C-dependent process [11] , we assessed the effect of 20-HETE on EDHF-mediated relaxation.
Incubation of precontracted rings of small coronary artery with 20-HETE (1 Amol/L) significantly inhibited EDHF-mediated relaxations (Fig. 4A) . R max was reduced from 79.4F7.3% in the presence of solvent to 36.6F15.7% in the presence of 20-HETE ( Pb0.01, n=6). In arteries pretreated with 20-HETE in the presence of the PKC inhibitor Ro 31-8220 (300 nmol/L), R max was restored to 86.4F6.9% ( Pb0.01, n=6; Fig. 4A ). EDHF-mediated relaxations were also significantly inhibited by the PKC activator PMA (1 Amol/L), an effect that was also sensitive to Ro 31-8220. R max was reduced from 76.8F4.3% in the presence of solvent to 6.3F3.2% in the presence of PMA but increased to 82.5F7.5% in the presence of PMA and Ro 31-8220 ( Pb0.001, n=5; Fig. 4B ). . Experiments were performed using endothelium-intact (+E) and endothelium-denuded arteries (ÀE). All experiments were performed in the presence of diclofenac (10 Amol/L) and the data represent the meanFS.E.M. from three to five different experiments.
Effect of 20-HETE on PKC activation
Since the inhibitory effect of 20-HETE on EDHFmediated relaxations was sensitive to a PKC inhibitor, we assessed the effect of 20-HETE on the phosphorylation of PKC in the Triton X-100-insoluble fraction of small porcine coronary arteries which is thought to contain active PKC isoforms [21] . The phospho-PKC antibody used detects PKCa, hI, hII,~, q, and y isoforms only when phosphorylated at a carboxy terminal residue.
A basal PKC phosphorylation was detected in the Triton X-100-insoluble fraction of unstimulated arteries. PMA and 20-HETE increased PKC phosphorylation, effects that were prevented by pretreatment with Ro 31-8220. Moreover, isometric stretch, which increases 20-HETE production in small coronary arteries, also increased PKC phosphorylation. The latter response was prevented by the PKC inhibitor as well as by DDMS (Fig. 5A) .
As PKCa has been implicated in 20-HETE-mediated responses [22, 23] , experiments were repeated using an antibody that specifically recognizes the phosphorylated form of PKCa. We observed that PMA, 20-HETE, and isometric stretch induced the Ro 31-8220-sensitive phosphorylation of PKCa in the cell membrane (Triton X-100-insoluble) fraction. Slight increases in PKCa levels in the membrane fraction were only observed in vessels treated with PMA. Most importantly, the isometric stretch-induced phosphorylation of PKCa in the membrane fraction was sensitive to DDMS.
Discussion
The results of the present study indicate that small branches of porcine coronary arteries express the CYP 4A N-hydroxylase and generate 20-HETE when subjected to isometric stretch or stimulated with the thromboxane analogue U46619. The 20-HETE endogenously generated in this manner functionally antagonizes the EDHF-mediated relaxation of these vessels. At least part of the action of 20-HETE can be attributed to the activation of PKC which inactivates the Na-K-ATPase, the main effector of EDHFmediated relaxation in these vessels.
Several distinct cellular mechanisms have been proposed to account for the phenomenon of EDHF-mediated relaxation (for a recent review, see Ref. [24] ). To date, the activation of K Ca + channels in endothelial cells and the subsequent efflux of K + and activation of inwardly rectifying K + channels or the Na-K-ATPase in smooth muscle cells have been suggested to account for relaxation in various vascular beds [25] . In coronary arteries, two additional btypesQ of EDHF have been proposed: the generation of hydrogen peroxide (H 2 O 2 ) [26] and the generation of EETs from arachidonic acid by CYP epoxygenases [20, 27] . Although the role for H 2 O 2 in EDHF-mediated vasodilatation is highly controversial, the bCYP-dependent EDHF Q that has been demonstrated in large porcine coronary arteries [20] as well as in human mammary arteries [28] , can be linked to the expression and activity of a CYP 2C epoxygenase [20, 29] and inhibited by so-called EET antagonists [30] . From the results of the present investigation, it appears that the mechanisms that underlie EDHF-mediated responses vary within the vascular tree. Indeed, although CYP 2C was expressed in large porcine coronary arteries, a markedly weaker signal was obtained in small arteries (300-500 Am) isolated from the same hearts. Moreover, while the CYP inhibitors miconazole, clotrimazole, and sulfaphenazole attenuate EDHFmediated responses in large coronary arteries [20] , all three were without effect on the smaller vessels investigated in this study. EDHF-mediated relaxation of small coronary arteries was however sensitive to the combination of charybdotoxin and apamin as well as to the Na-K-ATPase inhibitor ouabain and therefore appears similar to the EDHF-mediated responses detected in human and porcine interlobar arteries [31, 32] .
Although a CYP epoxygenase was not implicated in EDHF-mediated relaxation of small porcine coronary arteries, experiments using a PLA 2 inhibitor indicated that an endogenously generated prostanoid antagonized the EDHF-mediated relaxation. In addition, 17-ODYA and DDMS, a selective inhibitor of arachidonic acid N-hydroxylation [14, 33] , mimicked the effect of PLA 2 inhibition, suggesting the involvement of 20-HETE. Indeed, the exogenous application of 20-HETE markedly attenuated the bradykinin-induced, EDHF-mediated relaxation of U46619-precontracted coronary arteries. 20-HETE can induce contraction by two mechanisms, one endothelium-dependent involving the cyclooxygenasedependent generation of vasoconstrictor prostanoids, and the other endothelium-independent. The latter response is associated with inactivation of K Ca + channels [7, 23] , as well as the activation of Rho kinase, the phosphorylation of MLC20 and the sensitization of the contractile apparatus to Ca 2+ [12] . Although we previously found no evidence to indicate that the 20-HETE-induced and Rho kinase-dependent contraction of small porcine coronary arteries involves the activation of this kinase [12] , 20-HETE is reported to activate PKC in different cell types and thus influence K Ca + channel activity (for review, see Ref. [34] ). The results of the present study clearly indicate that the inhibition of EDHF-mediated relaxation by 20-HETE also occurs via a PKCa-dependent process. Indeed, the effect of 20-HETE could be mimicked by PMA and prevented by a PKC inhibitor. Moreover, the activation of PKC by isometric stretch was not observed when the production of 20-HETE was prevented. Given that 20-HETE is reported to inhibit the Na-K-ATPase via a PKCdependent mechanism and that the EDHF-mediated relaxation of small porcine coronary arteries is highly sensitive to ouabain, it is tempting to suggest that the functional antagonism of the EDHF-response occurs at the level of the ATPase.
Our report is not the first to suggest that coronary artery contraction antagonizes EDHF-mediated vasodilatation. Pressure-induced myogenic contraction of coronary arterioles, for example, has been reported to attenuate EDHFmediated responses, most probably by interfering with K Ca + channel activation [35] . Whether this effect is related to the generation of 20-HETE was not determined but in canine basilar arteries, 20-HETE potentiates stretch-induced contraction via the PKC-mediated inhibition of K Ca + channels [23] . Both the latter observations and the results of the present investigation could reflect different steps in the same process.
It has been proposed that the production of 20-HETE can be attenuated by endothelium-derived NO. Indeed, the inhibition of endogenous 20-HETE formation by NO may account for some of the cyclic GMP-independent effects of NO on vascular tone [14, 36] . However, although we previously reported that isometric stretch increases NO production [37] , the fact that DDMS attenuated the U46619-induced contraction of small porcine coronary arteries in the absence of a NO synthase inhibitor implies that, under the control conditions, the U46619-induced contraction was associated with an increase in 20-HETE production although the NO synthase was active. Indeed, much of the evidence obtained to date that indicates that 20-HETE acts as a second messenger in the signaling cascades activated by endothelin-1 [38] and angiotensin II [39] were obtained in preparations/situations in which NO synthases were not inhibited.
Vascular disease states are generally associated with attenuated endothelium-dependent relaxation and a decrease in the bioavailability of NO. In such situations, EDHF has been proposed to act as a bback-upQ vasodilator system. However, in situations associated with enhanced myogenic contraction or even coronary vasospasm, the increase in 20-HETE production, by antagonizing the EDHF-mediated relaxation, could severely compromise the vasodilator capacity of such vessels. It will therefore be interesting to determine whether coronary artery disease is associated with changes in the activity and/or expression of CYP 4A and whether CYP 4A represents a novel therapeutic target.
